Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

5.8K
The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
5.8K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

4.9K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
4.9K
Cancer-Critical Genes I: Proto-oncogenes01:33

Cancer-Critical Genes I: Proto-oncogenes

11.6K
Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
11.6K
Tumor Progression02:07

Tumor Progression

7.5K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
7.5K
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

9.9K
Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
9.9K
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

7.4K
Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
7.4K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Non-Destructive Blade Sharpness Characterization Using a High-Shear Responsive Fluid and Analytical Drag Modeling.

Nature communications·2026
Same author

Ultrasensitive low-density lipoprotein monitoring in early cardiovascular risk assessment via Cu-MOF-Apt/MoSâ‚‚ fluorescent nanosensor.

Spectrochimica acta. Part A, Molecular and biomolecular spectroscopy·2026
Same author

Targeting m6A-SCG2-TAMs axis overcomes 5-FU resistance in colorectal cancer via a multi-omics model.

NPJ digital medicine·2026
Same author

The interplay between mental health, ecological factors, and problematic smartphone use: a network analysis in adolescents with major depressive disorder.

European archives of psychiatry and clinical neuroscience·2026
Same author

A selective BRG1 inhibitor targeting bromodomain sensitizes hepatocellular carcinoma to chemoradiotherapy by disrupting the DNA damage response.

Chinese medical journal·2026
Same author

Machine learning based on body composition radiomics for predicting early recurrence in colorectal cancer: a multicenter study.

Frontiers in nutrition·2026

Related Experiment Video

Updated: Feb 21, 2026

Utilizing 18F-FDG PET/CT Imaging and Quantitative Histology to Measure Dynamic Changes in the Glucose Metabolism in Mouse Models of Lung Cancer
06:51

Utilizing 18F-FDG PET/CT Imaging and Quantitative Histology to Measure Dynamic Changes in the Glucose Metabolism in Mouse Models of Lung Cancer

Published on: July 21, 2018

18.8K

Oncogenic LPCAT1 Accelerates Intrahepatic Cholangiocarcinoma Development Through PI3K/Akt Signaling-Dependent Cell

Enlai Jiang1, Yuwei Chen2, Menglin Chen2

  • 1Department of General Surgery, Xinqiao Hospital, Army Medical University, Chongqing, China.

Journal of Gastroenterology and Hepatology
|February 19, 2026
PubMed
Summary

Lysophosphatidylcholine acyltransferase 1 (LPCAT1) is upregulated in intrahepatic cholangiocarcinoma (ICC). LPCAT1 promotes ICC progression by activating the PI3K/AKT pathway, increasing cell proliferation.

Keywords:
ICCLPCAT1cell cycle

More Related Videos

A Multiplexed Luciferase-based Screening Platform for Interrogating Cancer-associated Signal Transduction in Cultured Cells
10:13

A Multiplexed Luciferase-based Screening Platform for Interrogating Cancer-associated Signal Transduction in Cultured Cells

Published on: July 3, 2013

11.7K
Oncogene Expression Analysis with Alterations in pH in a Pancreatic Ductal Cell Line
06:24

Oncogene Expression Analysis with Alterations in pH in a Pancreatic Ductal Cell Line

Published on: April 11, 2025

956

Related Experiment Videos

Last Updated: Feb 21, 2026

Utilizing 18F-FDG PET/CT Imaging and Quantitative Histology to Measure Dynamic Changes in the Glucose Metabolism in Mouse Models of Lung Cancer
06:51

Utilizing 18F-FDG PET/CT Imaging and Quantitative Histology to Measure Dynamic Changes in the Glucose Metabolism in Mouse Models of Lung Cancer

Published on: July 21, 2018

18.8K
A Multiplexed Luciferase-based Screening Platform for Interrogating Cancer-associated Signal Transduction in Cultured Cells
10:13

A Multiplexed Luciferase-based Screening Platform for Interrogating Cancer-associated Signal Transduction in Cultured Cells

Published on: July 3, 2013

11.7K
Oncogene Expression Analysis with Alterations in pH in a Pancreatic Ductal Cell Line
06:24

Oncogene Expression Analysis with Alterations in pH in a Pancreatic Ductal Cell Line

Published on: April 11, 2025

956

Area of Science:

  • Oncology
  • Molecular Biology
  • Biochemistry

Background:

  • Intrahepatic cholangiocarcinoma (ICC) is an aggressive liver cancer with poor prognosis.
  • Phospholipid metabolism dysregulation is linked to tumorigenesis.
  • Lysophosphatidylcholine acyltransferase (LPCAT) family members are key enzymes in cancer, but their role in ICC is unknown.

Purpose of the Study:

  • To investigate the expression and function of LPCAT family members in ICC.
  • To elucidate the underlying molecular mechanisms of LPCAT1 in ICC progression.

Main Methods:

  • Immunohistochemistry to assess LPCAT1 expression in ICC tissues.
  • In vitro and in vivo assays to evaluate LPCAT1's role in cell proliferation, apoptosis, and tumor growth.
  • RNA sequencing and multiplex immunohistochemistry to explore signaling pathways.

Main Results:

  • LPCAT1 is significantly upregulated in human and murine ICC tissues and correlates with poor prognosis.
  • LPCAT1 manipulation affects ICC cell proliferation and tumor growth in vitro and in vivo.
  • LPCAT1 activates the PI3K/AKT pathway, upregulating cell cycle proteins and promoting ICC progression.

Conclusions:

  • LPCAT1 is a key driver of ICC progression.
  • LPCAT1 promotes ICC by activating the PI3K/AKT pathway, leading to increased cell cycle protein expression and proliferation.
  • LPCAT1 represents a potential therapeutic target for ICC.